Abstract
Aim:
DNA methylation regulates gene expression, and hypomethylation is associated with abnormal T-cell function in systemic lupus erythematosus (SLE). However, little is known about the methylation levels of the interleukin (IL)-4 and -6 promoters in SLE patients.
Methods:
T cells were isolated from 20 SLE patients and 10 healthy controls, activated in vitro in the presence or absence of 5-azacytidine (5-azaC), and their IL-4 and -6 transcripts were characterized using semiquantitative RT-PCR. Following bisulfate modification of their genomic DNA, the levels of DNA methylation in the IL-4 or -6 promoter were determined by nested PCR and direct sequencing.
Results:
The levels of IL-4 and -6 mRNA transcripts were significantly higher in SLE T cells, as compared with that in the controls. Furthermore, the treatment of healthy T cells with 5-azaC demethylated the CpG islands in the IL-4 or -6 promoter and increased IL-4 and -6 mRNA transcriptions. Importantly, the hypomethylation of the CpG islands in the IL-4 and -6 promoters displayed in SLE patients was similar to that of healthy T cells treated with 5-azaC. Finally, the hypomethylation levels of the CpG islands in the IL-4 and -6 promoters in lupus patients were significantly correlated to the IL-4 and -6 expressions.
Conclusion:
The hypomethylation of the CpG islands of the IL-4 and -6 promoters accrued in T cells from SLE patients and was associated with the severity of SLE at the clinic.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Fitzpatrick DR, Wilson CB . Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003; 109: 37–45.
Richardson BC . Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: S2401–5.
Nazarenko SA . Impaired epigenetic gene activity regulation and human diseases. Vestn Ross Akad Med Nauk 2001; 10: 43–8.
Turek-Plewa J, Jagodziñski PP . The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005; 10: 631–47.
Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61–5.
Cedar H . DNA methylation and gene activity. Cell 1988; 53: 3–4.
Sekigawa I, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H . DNA methylation in systemic lupus erythematosus. Lupus 2003; 12: 79–85.
Januchowski R, Prokop J, Jagodziñski PP . Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet 2004; 45: 237–48.
Nijnik A, Ferry H, Lewis G, Rapsomaniki E, Leung JC, Daser A, et al. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int Immunol 2006; 18: 1127–37.
Zhu J, Liu X, Xie C, Yan M, Yu Y, Sobel ES, et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 2005; 115: 1869–78.
Januchowski R, Wudarski M, Chwaliñska-Sadowska H, Jagodzinski PP . Prevalence of ZAP-70, LAT, SLP-76, and DNA methyl-transferase 1 expression in CD4(+) T cells of patients with systemic lupus erythematosus. Clin Rheumatol 2008; 27: 21–7.
Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M . Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665–73.
Richardson B . DNA methylation and autoimmune disease. Clin Immunol 2003; 109: 72–9.
Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S, et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004; 50: 1850–60.
Lu Q, Wu A, Ray D, Deng C, Attwood J, Hanash S, et al. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 2003; 170: 5124–32.
Lu Q, Ray D, Gutsch D, Richardson B . Effect of DNA methylation and chromatin structure on ITGAL expression. Blood 2002; 99: 4503–8.
Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38–53.
Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC . Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995; 154: 3025–35.
Andrews DF, Nemunaitis J, Tompkins C, Singer JW . Effect of 5-azacytidine on gene expression in marrow stromal cells. Mol Cell Biol 1989; 9: 2748–51.
Gómez D, Correa PA, Gómez LM, Cadena J, Molina JF, Anaya JM . Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 2004; 33: 404–13.
Linker-Israeli M, Honda M, Nand R, Mandyam R, Mengesha E, Wallace DJ, et al. Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC. Clin Immunol 1999; 91: 6–16.
Csiszár A, Nagy G, Gergely P, Pozsonyi T, Pócsik E . Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 2000; 122: 464–70.
Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD, et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1999; 1: 45–52.
McMurray RW, Hoffman RW, Nelson W, Walker SE . Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus—analyses of strain, gender, and age effects. Clin Immunol Immunopathol 1997; 84: 260–8.
Yung R, Powers D, Johnson K, Amento E, Carr D, Laing T, et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest 1996; 97: 2866–71.
Richardson B, Ray D, Yung R . Murine models of lupus induced by hypomethylated T cells. Methods Mol Med 2004; 102: 285–94.
Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282–91.
Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarrés M . Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol 2007; 81: 1609–16.
Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y, et al. DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006; 6: 99–106.
McCubbin MD, Hou G, Abrams GD, Dick R, Zhang Z, Brewer GJ . Tetrathiomolybdate is effective in a mouse model of arthritis. J Rheumatol 2006; 33: 2501–6.
Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005; 202: 1131–9.
Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A . Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603–7.
Ballestar E, Esteller M, Richardson BC . The epigenetic face of systemic lupus erythematosus. J Immunol 2006; 176: 7143–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mi, Xb., Zeng, Fq. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 29, 105–112 (2008). https://doi.org/10.1111/j.1745-7254.2008.00739.x
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00739.x
Keywords
This article is cited by
-
Association of Promoter Methylation and Expression of Inflammatory Genes IL-6 and TNF-α with the Risk of Coronary Artery Disease in Diabetic and Obese Subjects among Asian Indians
Indian Journal of Clinical Biochemistry (2022)
-
Dual Effect of IL-6 -174 G/C Polymorphism and Promoter Methylation in the Risk of Coronary Artery Disease Among South Indians
Indian Journal of Clinical Biochemistry (2019)
-
Genetic and epigenetic influences on the loss of tolerance in autoimmunity
Cellular & Molecular Immunology (2018)
-
Translating epigenetics into clinic: focus on lupus
Clinical Epigenetics (2017)
-
Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus
Immunologic Research (2016)
